What's New

License-Out

License Agreement Has Been Entered into with Medicines Discovery Catapult Ltd.

We have executed a non-exclusive license agreement with Medicines Discovery Catapult Ltd. (Cheshire, U.K.) for allowing them to provide services using iPS cell-derived neurons, hepatocytes, etc. for user's research purposes under the patents on iPS cell technologies licensed to us by Kyoto University.

Medicines Discovery Catapult Ltd.

Back to top